İctimai Səhiyyə və İslahatlar Mərkəzində hazırlanmışdır.
Document Outline
Obloshka Hepatit C.pdf
Hepatitis C_A5 for Web.pdf
1. Helen S Yee, Sue L Currie, Jama M Darling and Teresa L Wright M. Management and treatment of hepatitis C viral infection: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center program and the National Hepatitis C Program office. American Journal of Gastroenterology 2006;101:2360-2378.
2. Strader DB, Wright T, Thomas DL, Seeff LB. AASLD PRACTICE GUIDELINE: Diagnosis, Management, and Treatment of Hepatitis C. Hepatology. 2004;39:1147-1171.
3. National Kidney Foundation 2008 Spring Clinical Meetings: Session 285. Guidelines for Hepatitis C in Chronic Kidney Disease. April 2–6, 2008.Kidney Intl. 2008;73(suppl 109):S1-S99.
4. Alfredo Alberti, Nathan Clumeck, Simon Collins, Wolfram Gerlich, Jens Lundgren, Giorgio Palú, Peter Reiss, Rodolphe Thiebaut, OlaWeiland, Yazdan Yazdanpanah, Stefan Zeuzem. Short Statement of the First European Consensus Conference on the Treatment of Chronic Hepatitis В and C in HIV Co-Infected Patients. Journal of Hepatology 2005; 42:615-624.
6. Heller T and Rehermann B (2005) Acute hepatitis C: a multifaceted disease. Semin Liver Dis 25: 7–17
7. В. Hofer H et al. (2003) Spontaneous viral clearance in patients with acute hepatitis C can be predicted by repeated measurements of serum viral load. Hepatology 37: 60–64
8. Zekry A et al. (2005) Treatment of acute hepatitis C infection: more pieces of the puzzle? J Hepatol 42: 293–296
9. Jaeckel E et al. (2001) Treatment of acute hepatitis C with interferon alfa-2b. N Engl J Med 345: 1452–1457
10. Kamal SM et al. (2006) Duration of peginterferon therapy in acute hepatitis C: a randomized trial. Hepatology 43: 923–931
11. Wiegand J et al. (2006) Early monotherapy with pegylated interferon alpha-2b for acute hepatitis C infection: the HEP-NET acute-HCV-II study. Hepatology 43: 250–256
12. Roberts SK, Cooksley G, Dore GJ, et al. Robust antiviral activity of R1626, a novel nucleoside analog: A randomized, placebo-controlled study in patients with chronic hepatitis C. Hepatology. 2008; 48:398-406.